在肝硬化中,人类肠道微生物组的改变
Nan Qin1, Fengling Yang2, Ang Li2
11] State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, 310003 Hangzhou, China [2] Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, 310003 Hangzhou, China [3].
Nature
|August 1, 2014
概括
这项研究揭示了肝硬化患者肠道微生物组的显著变化,确定了特定的细菌基因,并表明口腔细菌的入侵. 这些发现使得使用新型微生物群生物标志物的准确诊断成为可能.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 基因组学就是基因组学.
背景情况:
- 肝硬化是全球慢性肝病的一个严重后果.
- 了解肠道微生物群在肝硬化中的作用对于疾病管理至关重要.
研究的目的:
- 在肝硬化患者的肠道微生物组合的特征.
- 确定用于肝硬化诊断的新型微生物生物标志物.
主要方法:
- 在98名肝硬化患者和83名健康对照人群中对肠道微生物群进行了比较性元基因组学分析.
- 构建一个全面的队列特异性基因组.
- 基于已识别的生物标志物的诊断指数的开发和验证.
主要成果:
- 建立了269万个基因的参考基因组,其中36.1%是新型基因.
- 在患者和对照组中,分别发现了75,245个不同丰富的基因.
- 54%的患者丰富的物种来自口腔,这表明口腔肠道转移.
结论:
- 肠道微生物组失调是肝硬化的一个标志.
- 针对微生物群的生物标志物为准确和早期疾病诊断提供了一个有希望的途径.
- 鉴定到的生物标志物可以区分肝硬化与其他疾病,如2型糖尿病和炎症性肠病.
相关概念视频
Cirrhosis I: Introduction
25
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
25
Cirrhosis II: Pathophysiology
33
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
33
Development of Human Microbiota
60
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
60
Microbiota of the Large Intestine
94
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
94
Introduction to the Human Microbiota
162
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
162
Functions of the Gut Microbiota
145
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
145


